ABSTRACT: Ovarian dysfunction and lower circulating anti-Müllerian hormone (AMH) feature women living with HIV (WLWH). Because treated human immunodeficiency virus (HIV) infection is characterized by a pro-inflammatory/oxidative phenotype resulting in residual comorbidity, we sought to investigate possible associations between plasma AMH and markers of inflammation, immune activation/senescence/exhaustion, oxidative stress as well as comorbidities in a cohort of combined anti-retroviral therapy (cART)-treated WLWH versus age-matched HIV-uninfected, healthy women.Eighty WLWH on effective cART aged 25 to 50 years and 66 age-matched healthy women were enrolled. We measured: plasma AMH, IL-6, reactive oxygen species modulator 1 (ROMO1) (ELISA); plasma tumor necrosis factor α, IL-10, soluble vascular cell adhesion molecule 1, osteopontin (Luminex); CD4/CD8 activation (CD38/CD69), apoptosis (CD95), exhaustion (PD1), maturation (CD45RA/CD45R0/CD127/CCR7), recent thymic emigrants (CD31/CD103) (flow cytometry). Mann Whitney and chi-squared tests were used. Univariate and multivariate logistic regression analyses were used to assess factors associated with low AMH (≤1 ng/mL).Compared to healthy women, WLWH were more frequently non-Caucasian, drug/alcohol abusers, with history of late menarche, lower hormonal contraceptive use, with higher gravidity and lower parity. WLWH showed significantly lower AMH (P = .004) as well as higher ROMO1 (P = .0003) and tumor necrosis factor α (P < .0001). The multivariate analyses revealed ROMO1 (adjusted odds ratio [AOR]: 1.42, P = .03) and HIV infection (AOR: 8.1, P = .0001) as independently associated with low AMH. The logistic regression model with both HIV status and ROMO1 (a marker of oxidative stress) confirmed HIV as the only predictor of low AMH (AOR: 17, P = .0003).Despite effective cART, WLWH showed lower AMH compared to age-matched peers, indicating pre-mature ovarian ageing. Both HIV and oxidative stress are independently associated with low AMH, emphasizing the impact of HIV-associated oxidative stress on reproductive aging.

Predictors of low ovarian reserve in cART-treated women living with HIV / E. Merlini, C. Tincati, V. Sacchi, M. Augello, V. Bono, E.S. Cannizzo, M. Allegrini, L. Gazzola, A.D. Monforte, A.M. Marconi, M. Ravizza, G. Marchetti. - In: MEDICINE. - ISSN 1536-5964. - 100:39(2021 Oct), pp. e27157.1-e27157.8. [10.1097/MD.0000000000027157]

Predictors of low ovarian reserve in cART-treated women living with HIV

E. Merlini
Primo
;
C. Tincati;V. Sacchi;M. Augello;V. Bono;E.S. Cannizzo;M. Allegrini;L. Gazzola;A.D. Monforte;A.M. Marconi;G. Marchetti
2021

Abstract

ABSTRACT: Ovarian dysfunction and lower circulating anti-Müllerian hormone (AMH) feature women living with HIV (WLWH). Because treated human immunodeficiency virus (HIV) infection is characterized by a pro-inflammatory/oxidative phenotype resulting in residual comorbidity, we sought to investigate possible associations between plasma AMH and markers of inflammation, immune activation/senescence/exhaustion, oxidative stress as well as comorbidities in a cohort of combined anti-retroviral therapy (cART)-treated WLWH versus age-matched HIV-uninfected, healthy women.Eighty WLWH on effective cART aged 25 to 50 years and 66 age-matched healthy women were enrolled. We measured: plasma AMH, IL-6, reactive oxygen species modulator 1 (ROMO1) (ELISA); plasma tumor necrosis factor α, IL-10, soluble vascular cell adhesion molecule 1, osteopontin (Luminex); CD4/CD8 activation (CD38/CD69), apoptosis (CD95), exhaustion (PD1), maturation (CD45RA/CD45R0/CD127/CCR7), recent thymic emigrants (CD31/CD103) (flow cytometry). Mann Whitney and chi-squared tests were used. Univariate and multivariate logistic regression analyses were used to assess factors associated with low AMH (≤1 ng/mL).Compared to healthy women, WLWH were more frequently non-Caucasian, drug/alcohol abusers, with history of late menarche, lower hormonal contraceptive use, with higher gravidity and lower parity. WLWH showed significantly lower AMH (P = .004) as well as higher ROMO1 (P = .0003) and tumor necrosis factor α (P < .0001). The multivariate analyses revealed ROMO1 (adjusted odds ratio [AOR]: 1.42, P = .03) and HIV infection (AOR: 8.1, P = .0001) as independently associated with low AMH. The logistic regression model with both HIV status and ROMO1 (a marker of oxidative stress) confirmed HIV as the only predictor of low AMH (AOR: 17, P = .0003).Despite effective cART, WLWH showed lower AMH compared to age-matched peers, indicating pre-mature ovarian ageing. Both HIV and oxidative stress are independently associated with low AMH, emphasizing the impact of HIV-associated oxidative stress on reproductive aging.
No
English
anti-Mullerian hormone; HIV infection; inflammation; ovarian reserve; oxidative stress; reproductive aging; Adult; Anti-Mullerian Hormone; Anti-Retroviral Agents; Drug Combinations; Female; HIV Infections; Humans; Middle Aged; Ovarian Reserve
Settore MED/40 - Ginecologia e Ostetricia
Articolo
Esperti anonimi
Pubblicazione scientifica
ott-2021
Wolters Kluwer Health, Inc.
100
39
e27157
1
8
8
Pubblicato
Periodico con rilevanza internazionale
scopus
wos
pubmed
crossref
Aderisco
info:eu-repo/semantics/article
Predictors of low ovarian reserve in cART-treated women living with HIV / E. Merlini, C. Tincati, V. Sacchi, M. Augello, V. Bono, E.S. Cannizzo, M. Allegrini, L. Gazzola, A.D. Monforte, A.M. Marconi, M. Ravizza, G. Marchetti. - In: MEDICINE. - ISSN 1536-5964. - 100:39(2021 Oct), pp. e27157.1-e27157.8. [10.1097/MD.0000000000027157]
open
Prodotti della ricerca::01 - Articolo su periodico
12
262
Article (author)
Periodico con Impact Factor
E. Merlini, C. Tincati, V. Sacchi, M. Augello, V. Bono, E.S. Cannizzo, M. Allegrini, L. Gazzola, A.D. Monforte, A.M. Marconi, M. Ravizza, G. Marchetti
File in questo prodotto:
File Dimensione Formato  
2021 - Merlini - Predictors_of_low_ovarian_reserve HIV - medicine.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 869.46 kB
Formato Adobe PDF
869.46 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/900434
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact